CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Tofacitinib for Immune Skin Conditions in Down Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04246372
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:51.015361+00:00
Published At: 2025-12-11T00:00:00+00:00
Record Updated At: 2025-12-11
Results Posted At: 2025-12-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Down Syndrome", "Alopecia Areata", "Atopic Dermatitis / Eczema", "Hidradenitis Suppurativa", "Vitiligo", "Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-11"
protocolSection.identificationModule.nctId: "NCT04246372"
protocolSection.identificationModule.officialTitle: "Safety and Efficacy of Tofacitinib for Immune Skin Conditions in Down Syndrome"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-12-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.